Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Slides:

Advertisements

Similar presentations

Photodynamic Laser Therapy for Lesions in the Airway

Advertisements

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Matthew J. Schuchert, MD, Kristen N

Arjun Pennathur, MD, Liqiang Xi, MD, Virginia R. Litle, MD, William E

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Andrew Feber, PhD, Liqiang Xi, MD, PhD, Arjun Pennathur, MD, William E

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Hanjay Wang, MD, David Kalfa, MD, PhD, Marlon S

Roux-en-Y Near Esophagojejunostomy for Failed Antireflux Operations: Outcomes in More Than 100 Patients Omar Awais, DO, James D. Luketich, MD, Neha Reddy,

Arjun Pennathur, MD, Andrew C. Chang, MD, Kevin M

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients Arjun Pennathur, MD, James.

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.

Bahaaldin Alsoufi, MD, Sally Cai, PhD, Glen S

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Roux-en-Y Near Esophagojejunostomy for Intractable Gastroesophageal Reflux After Antireflux Surgery Omar Awais, DO, James D. Luketich, MD, John Tam,

Matthew J. Schuchert, MD, Kristen N

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Acute Kidney Injury Increases Mortality After Lung Transplantation

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Adriaan W. Schneider, MD, Nico A. Blom, MD, PhD, Eline F

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Postesophagectomy Chylothorax: Incidence, Risk Factors, and Outcomes

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Philip A. Linden, MD, Jon O. Wee, MD, Michael T

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy Atsushi Yamaguchi, MD, Hideo Adachi, MD, Koji Kawahito, MD, Seiichiro.

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

Matthew J. Schuchert, MD, André P

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,

Pancreaticopleural Fistula Presenting as Right-Sided Hemothorax

Propensity Score Analysis Comparing Videothoracoscopic Lobectomy With Thoracotomy: A French Nationwide Study Pierre-Benoit Pagès, MD, PhD, Jean-Philippe.

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Omar Awais, DO, James D. Luketich, MD, Matthew J

Comparison of surgical techniques for early-stage thymoma: Feasibility of minimally invasive thymectomy and comparison with open resection Arjun Pennathur,

Matthew J. Schuchert, MD, Brian L

Phillip S. Naimo, BS, Matthew S

Wilson Y. Szeto, MD, Joseph E. Bavaria, MD, Frank W

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Radiofrequency Ablation for the Treatment of Pulmonary Metastases Arjun Pennathur, MD, Ghulam Abbas, MD, Irfan Qureshi, MD, Matthew J. Schuchert, MD, Yun Wang, PhD, Sebastien Gilbert, MD, Rodney J. Landreneau, MD, James D. Luketich, MD The Annals of Thoracic Surgery Volume 87, Issue 4, Pages 1030-1039 (April 2009) DOI: 10.1016/j.athoracsur.2008.12.061 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier analysis illustrates the overall survival for all patients. The time shown in the x-axis is months from radiofrequency ablation. The dashed lines are Greenwood 95% confidence bands for the probability of overall survival. The Annals of Thoracic Surgery 2009 87, 1030-1039DOI: (10.1016/j.athoracsur.2008.12.061) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier analysis illustrates the overall survival stratified by lesion size ≤3 cm (solid line) and >3 cm (dashed line). The time shown in the x-axis is months from radiofrequency ablation. The number of patients at risk is shown above the x-axis. (Log-rank p = 0.002.) The Annals of Thoracic Surgery 2009 87, 1030-1039DOI: (10.1016/j.athoracsur.2008.12.061) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier analysis illustrates the progression-free survival stratified by lesion size ≤3 cm (solid line) and >3 cm (dashed line). The time shown in the x-axis is months from radiofrequency ablation. The number of patients at risk is shown above the x-axis. (Log-rank p = 0.01.) The Annals of Thoracic Surgery 2009 87, 1030-1039DOI: (10.1016/j.athoracsur.2008.12.061) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions